Polygenic Risk Score Added to Conventional Case Finding to Identify Undiagnosed Chronic Obstructive Pulmonary Disease
Authors:
- 4 March 2025
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 333 (9) , 784
Abstract
Importance: Chronic obstructive pulmonary disease (COPD) is often undiagnosed. Although genetic risk plays a significant role in COPD susceptibility, its utility in guiding spirometry testing and identifying undiagnosed cases is unclear.Objective: To determine whether a COPD polygenic risk score (PRS) enhances the identification of undiagnosed COPD beyond a case-finding questionnaire (eg, the Lung Function Questionnaire) using conventional risk factors and respiratory symptoms.Design, Setting, and Participants: This cross-sectional analysis of participants 35 years or older who reported no history of physician-diagnosed COPD was conducted using data from 2 observational studies: the community-based Framingham Heart Study (FHS) and the COPD-enriched Genetic Epidemiology of COPD (COPDGene) study.Exposures: Modified Lung Function Questionnaire (mLFQ) scores and COPD PRS.Main Outcomes and Measures: The primary outcome was spirometry-defined moderate to severe COPD (forced expiratory volume in the first second of expiration/forced vital capacity [FEV1/FVC] 1 [percent predicted] P < .001) in FHS, 0.69 to 0.72 (P = .04) in COPDGene non-Hispanic African American, and 0.75 to 0.78 (P < .001) in COPDGene non-Hispanic White participants. At a risk threshold for spirometry referral of 10%, the addition of the PRS to the mLFQ score correctly reclassified 13.8% (95% CI, 6.6%-21.0%) of COPD cases in FHS, but not in COPDGene.Conclusions and Relevance: A COPD PRS enhances the identification of undiagnosed COPD beyond a conventional case-finding approach in the general population. Further research is needed to assess its impact on COPD diagnosis and outcomes.Keywords
This publication has 35 references indexed in Scilit:
- Global Burden of Chronic Obstructive Pulmonary Disease Through 2050JAMA Network Open, 2023
- Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene–environment interactions across the lifespanThe Lancet Respiratory Medicine, 2022
- Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry Among Ever SmokersChest, 2022
- Portability of 245 polygenic scores when derived from the UK Biobank and applied to 9 ancestry groups from the same cohortThe American Journal of Human Genetics, 2022
- Cost Effectiveness of Case Detection Strategies for the Early Detection of COPDApplied Health Economics and Health Policy, 2020
- Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohortsThe Lancet Respiratory Medicine, 2020
- Analysis of polygenic risk score usage and performance in diverse human populationsNature Communications, 2019
- Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort studyThe Lancet Respiratory Medicine, 2017
- Targeted case finding for chronic obstructive pulmonary disease versus routine practice in primary care (TargetCOPD): a cluster-randomised controlled trialThe Lancet Respiratory Medicine, 2016
- Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ)Respiratory Medicine, 2010